Liposomes coated with chemically modified dextran interact with human endothelial cells

Journal of Biomedical Materials Research

Volumn 44, Issue 2, 1999, Pages 140-148

  Cansell, Maud ^a   Parisel, Claire ^a   Jozefonvicz, Jacqueline ^a   Letourneur, Didier ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Derivatized dextrans; Dextran coating; Endocytosis; Human endothelial cells; Liposomes

Indexed keywords

CELLS; CHOLESTEROL; DERIVATIVES; LIPIDS; POLYSACCHARIDES;

DRUG CARRIERS; ENDOTHELIAL CELLS; LIPOSOMES;

CONTROLLED DRUG DELIVERY;

CHOLESTEROL; DEXTRAN; DRUG CARRIER; DRUG VEHICLE; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID BILAYER;

BIOCOMPATIBLE MATERIALS; CALCIUM; CELL LINE; DEXTRANS; DRUG CARRIERS; DRUG STABILITY; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; HUMANS; LIPOSOMES; MATERIALS TESTING; SURFACE PROPERTIES;

EID: 0033080553     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199902)44:2<140::AID-JBM3>3.0.CO;2-5     Document Type: Article

References (46)

1. Allen TM. Liposomal drug delivery. Curr Opin Colloid Interfac Sci 1996;1:645-651.
2. Sato T, Sunamoto J. Recent aspects in the use of liposomes in biotechnology and medicine. Prog Lipid Res 1992;31:345-372.
3. Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phogocyte system. Adv Drug Deliv Rev 1994;13:285-309.
4. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 1988;85:6949-6953.
5. Kato E, Akiyoshi K, Furuno T, Nakanishi M, Kikuchi A, Kataoka K, Sunamoto J. Interactions between ganglioside-containing liposome and rat T-lymphocyte: Confocal fluorescence microscopic study. Biochim Biophys Res Commun 1994; 203:1750-1755.
6. Parr MJ, Ansell SM, Choi LS, Cullis PR. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta 1994;1195:21-30.
7. Ishiwata H, Vertut-Doï A, Hirose T, Miyajima K. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyetylene) cholestery ether. Chem Pharm Bull 1995;43:1005-1011.
8. Torchilin VP, Shtilman MI, Trubetskoy VS, Whiteman K, Milstein AM. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim Biophys Acta 1994; 1195:181-184.
9. Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov AA, Trubetskoy VS, Herron JN, Gentry CA. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994;1195:11-20.
10. Torchilin VP, Papisov MI. Hypothesis: Why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res 1994;4:725-739.
11. Osterberg E, Bergstrom K, Holmberg K, Schuman TP, Riggs JA, Burns NL, Van Alstine JM, and Harris JM. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: Comparison to PEG. J Biomed Mater Res 1995;29: 741-747.
12. Spragg DD, Alford DR, Greferath R, Larsen CE, Lee KD, Gurtner GC, Cybulsky MI, Tosi PF, Nicolau C, Gimbrone MA. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci USA 1997;94:8795-8800.
13. Allen TM, Moase EH. Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Deliv Rev 1996;2:117-133.
14. Sunamoto J, Sato T, Hirota M, Fukushima K, Hiratani K, Hara K. A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgM fragment. Biochim Biophys Acta 1987;898:323-330.
15. Elferink MGL, De Wit JG, In't Veld G, Reichert A, Driessen AJM, Ringsdorf H, Konings WN. The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups. Biochim Biophys Acta 1992;1106:23-30.
16. Sugimoto M, Ohishi K, Fukasawa M, Shikata K, Kawai H, Itakura H, Hatanaka M, Sakakibara R, Ishiguro M, Nakata M, Mizuochi T. Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett 1995; 363:53-56.
17. Jozefowicz M, Jozefonvicz J. Randomness and biospecificity: Random copolymers are capable of biospecific molecular recognition in living systems. Biomaterials 1997;18:1633-1644.
18. Chaubet F, Champion J, Maïaga O, Mauray S, Jozefonvicz J. Synthesis and structure-anticoagulant relationships of functionalized dextrans: CMDBS. Carbohydr Polym 1995;28:145-152.
19. Letourneur D, Logeart D, Avramoglou T, Jozefonvicz J. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth - the model of derivatized dextrans as heparin-like polymers. J Biomater Sci Polym Edn 1993;4:431-444.
20. Carré V, Mbemba E, Letourneur D, Jozefonvicz J, Gattegno L. Interactions of HIV-1 envelope glycoproteins with derivatized dextrans. Biochim Biophys Acta 1995;1243:175-180.
21. Neyts J, Reymen D, Letourneur D, Jozefonvicz J, Schols D, Este J, Andrei G, McKenna P, Witvrouw M, Ikeda S, De Clercq E. Differential antiviral activity of derivatized dextrans. Biochem Pharmacol 1995;50:743-751.
22. Thomas H, Maillet F, Letourneur D, Jozefonvicz J, Kazatckine MD. Effect of substituted dextran derivative on complement activation in vivo. Biomaterials 1995;16:1163-1167.
23. Letourneur D, Champion J, Slaoui F, Jozefonvicz J. In vitro stimulation of human endothelial cells by derivatized dextrans. In Vitro Cell Biol 1993;29:67-72.
24. Stearns NA, Prigent-Richard S, Letourneur D, Castellot JJ. Synthesis and characterization of highly sensitive heparin probes for detection of heparin-binding proteins. Anal Biochem 1997; 247:348-356.
25. Prigent-Richard S, Cansell M, Vassy J, Viron A, Puvion E, Jozefonvicz J, Letourneur D. Fluorescent and radiolabeling of polysaccharides: Binding and internalization experiments on vascular cells. J Biomed Mater Res 1998;40:275-281.
26. Akiyoshi K, Yamaguchi S, Sunamoto J. Self-aggregates of hydrophobic polysaccharide derivatives. Chem Lett 1991;1263-1266.
27. Seras-Cansell M, Sahli H, Dubois V, Letourneur D, Jozefonvicz J. Characterization of vesicles for vascular cell targeting: Influence of dextran coating. In: Ottenbrite R, editor. Frontiers in biomedical polymer applications Vol 1. Lancaster, PA. Technomic Publishing 1998. p 95-108.
28. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridation. Proc Natl Acad Sci USA 1983;80:3734-3737.
29. Emies JJ, Edgell CJS. Fibrinolytic properties of a human endothelial hybrid cell line (EA.hy 926). Blood 1988;71:1669-1675.
30. Letourneur D, Caleb BL, Castellot JJ. Heparin binding, internalization and metabolism in vascular smooth muscle cells. I. Upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol 1995;165:676-686.
31. Pain D, Das PK, Ghosh P, Bachhawat BK. Increased circulatory half-life of liposomes after conjunction with dextran. J Biosci 1984;6:811-816.
32. Herman S, Persijn G, Vanderkerckhove J, Schacht E. Synthesis of dextran derivatives with thiol-specific reactive groups for the preparation of dextran-protein conjugate. Bioconj Chem 1993;4:402-405.
33. Baudys M, Letourneur D, Liu F, Mix D, Jozefonvicz J, Kim SW. Extending insulin action in vivo by conjugation to carboxymethyl. Bioconj Chem 1998;9:176-183.
34. Vidal M, Hoekstra D. In vitro fusion of reticulocyte endocytic vesicles with liposomes. J Biol Chem 1995;270:17823-17829.
35. Arnold K, Ohki S, Krumbiege M. Interaction of dextran sulfate with phospholipid surfaces and liposome aggregation and fusion. Chem Phys Lipids 1990;55:301-307.
36. Ortiz A, Aranda FJ, Villalain J, San Martin C, Micol V, Gomez-Fernandez JC. 1,2-Dioleylglycerol promotes calcium-induced fusion in phospholipid vesicles. Chem Phys Lipids 1992;62: 215-224.
37. Holland JW, Hui C, Cullis PR, Madden TD. Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry 1996;35:2618-2624.
38. 2+-induced fusion of phosphatidylserine vesicles: Effects of poly(ethylene glycol). Biochim Biophys Acta 1994;1191:375-383.
39. Higashi N, Sunamoto J. Endocytosis of poly(ethylene oxide)-modified liposome by human lymphoblastoid cells. Biochim Biophys Acta 1995;1243:386-392.
40. Wrobel I, Collins D. Fusion of cationic liposomes with mamalian cells occurs after endocytosis. Biochim Biophys Acta 1995; 1235:295-304.
41. Higashi N, Yamauchi M, Okumura Y, Nakanishi M, Sunamoto J. Fusion between Jurkat cell and PEO-lipid modified liposome. Biochim Biophys Acta 1996;1285:183-191.
42. Cansell M, Gouygou J-P, Jozefonvicz J, Letourneur D. Lipid composition of cultured endothelial cells in relation to their growth. Lipids 1997;32:39-14.
43. Sahli A, Cansell M, Tapon-Bretaudiere J, Letourneur D, Jozefonvicz J, Fischer AM. The stability of heparin-coated liposomes in plasma and their effect on its coagulation. Colloids Surf B 1998;10:205-215.
44. Liu D, Liu F, Song YK. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim Biophys Acta 1995;1235:140-146.
45. Thomas H, Maillet F, Letourneur D, Jozefonvicz J, Kazatchkine MD, Fischer E. A substituted dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection. Mol Immunol 1996;33:643-648.
46. Parr MJ, Masin D, Culis PR, Bally MB. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: The lack of beneficial effects by coating with poly(ethylene glycol). J Pharmacol Exp Ther 1997;280:1319-1327.